tiprankstipranks
TipRanksTop Financial ExpertsInsidersRobert Azelby

Robert Azelby Insider Profile

4 Followers
Robert Azelby, Director at Autolus Therapeutics, holds ― shares in Autolus Therapeutics (Ticker: AUTL), holds 0.00 shares in Juno Therapeutics (Ticker: JUNO), holds ― shares in Cascadian Therapeutics (Ticker: CASC). Most recently, Robert Azelby ― shares of Autolus Therapeutics on ― for an estimated value of ―.
See the Hottest Stocks Based on Insider Trading >
tipranks
Robert Azelby

Robert Azelby
Autolus Therapeutics (AUTL)
Director

Not Ranked
Robert Azelby has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$1M
78.84%
11.23%
9.93%
0.00%
0.00% Others
A breakdown of Robert Azelby's holdings
See the Top Stocks by Insiders

Insider Roles

Cardinal Health
(CAH)
Director
Tango Therapeutics
(TNGX)
Director
ADC Therapeutics
(ADCT)
Director
Autolus Therapeutics
(AUTL)
Director
+1 other positions
Roles that Robert Azelby holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Robert Azelby
See the Latest Stocks Traded by Insiders

Robert Azelby's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AUTL
Autolus Therapeutics
―
Director
―
―
JUNO
Juno Therapeutics
Mar 07, 2018
―
Uninformative Sell
―
$0.00
CASC
Cascadian Therapeutics
―
―
―
―
ALDR
Alder Biopharmaceuticals
―
―
―
―
CLVSQ
Clovis Oncology
―
―
―
―
IMMU
Immunomedics
Jun 22, 2020
―
Uninformative Buy
―
$326.66K
CLYM
Climb Bio
―
President & CEO, Director
―
―
KDNY
Chinook Therapeutics
―
―
―
―
CAH
Cardinal Health
Nov 06, 2025
Director
Uninformative Buy
―
$958.22K
ADCT
ADC Therapeutics
Jun 03, 2026
Director
Uninformative Buy
―
$120.70K
TERN
Terns Pharmaceuticals
―
―
―
―
TNGX
Tango Therapeutics
Jun 23, 2026
Director
Uninformative Buy
―
$136.50K
List of latest transactions for each holding click on a transaction to see Robert Azelby's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Robert Azelby insider profile FAQ

What is the percentage of profitable transactions made by Robert Azelby?
The percentage of profitable transactions made by Robert Azelby is ―.
    What is the average return per transaction made by Robert Azelby?
    The average return per transaction made by Robert Azelby is ―.
      What stocks does Robert Azelby hold?
      Robert Azelby holds: AUTL, JUNO, CASC, ALDR, CLVSQ, IMMU, CLYM, KDNY, CAH, ADCT, TERN, TNGX stocks.
        What was Robert Azelby’s latest transaction?
        Robert Azelby latest transaction was an Uninformative Buy of ―.
          What was Robert Azelby's most profitable transaction?
          Robert Azelby’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Robert Azelby's role in Autolus Therapeutics?
            Robert Azelby's role in Autolus Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.